Raj et al. found that the drug BRM270 induced G2/M phase arrest, effectively inhibited proliferation, and induced apoptosis in hepatocellular carcinoma through downregulation of the Cyclin D1/Bcl2-mediated c-Jun apoptosis pathway [51]. Here, BCL2 is linked to hepatocellular carcinoma.